Flexiv Ltd., a global general-purpose robotics company, closed an over 100m USD Series B funding round.
Vetreska, a Chinese pet lifestyle brand, closed a $20M Series B financing round.
Transcenta Holding Limited, a global biotherapeutics company with integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, completed a 105m USD crossover financing.
ClassIn, a Beijing, China-based EdTech company creator of an online interactive classroom, raised $265m in Series C funding.
AInnovation, a Beijing, China-based artificial intelligence company, completed a Series C financing round of undisclosed amount.
dMed, a Shangai, China-based clinical CRO, completed a US$100m Series C financing.
vesoft Inc., a Hangzhou, China-based developer of the Nebula Graph™ database, raised an additional $10m in a series pre-A+ funding round.
Beacon Education, a Beijing-based provider of online degrees to China, closed a $6M Series B financing round.
Eluminex Biosciences Limited, a Shangai, China-based ophthalmic biotechnology company, completed a $50m (USD) Series A financing.
IceKredit, a Shangai, China-based AI powered platform for business, closed a $33m series C1 round of funding.
Clinical-stage Asia-Pacific biopharmaceutical company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited on Nov. 20, 2020.
Qiming Venture Partners, a Shangai, China-based venture capital firm, closed Qiming Venture Partners Fund VII, at $1.2 billion.
D3 Bio, a Shangai, China-based global biotechnology company focused on developing and commercializing precision medicines to improve or replace existing standard-of-care treatments that do not fully meet patient needs, launched today with US$200m in Series A financing.
Wuxi Biortus Biosciences Co. Ltd., a Wuxi, China-based leader in structural biology service for drug discovery, closed a US$15m Series A financing.
Zilliz, a Shangai, China-based AI-powered unstructured data analytics startup, closed a $43m Series B funding.